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Abstract 
Introduction: Chlorpyrifos (CPF) is an organophosphate insecticide reported to induce both after acute and repeated exposure 
learning and memory dysfunctions, although the mechanism is not completely known. CPF produces basal forebrain cholinergic 
neuronal loss, involved on learning and memory regulation, which could be the cause of such cognitive disorders. This effect was 
reported to be mediated through apoptotic process, although neuronal necrosis was also described after CPF exposure. Otherwise, 
neuronal dendritic spines were reported to be also involved on learning and memory process regulation and their alteration could also 
contribute to this effect. In this regard, CPF has been reported to induce an alteration in the dendritic spines density in the prefrontal 
cortex and hippocampus after acute and repeated exposure to subclinical doses respectively, thus their alteration in basal forebrain 
cholinergic neurons could also mediate cognitive disorders. 
Objectives and methods: Accordingly, we hypothesized that CPF induces basal forebrain cholinergic dendritic spine alteration at 
low concentrations and at higher concentrations produces necrotic and apoptotic cell death. We evaluated in septal SN56 basal 
forebrain cholinergic neurons, the CPF effect after 24 h and 14 days exposure on dendritic spines, the necrosis induction and the 
apoptotic and necrotic gene expression pathways. 
Results: This study shows that CPF induces after acute and long-term exposure an alteration of dendritic spines at lower concen-
trations than which induces cell death. Evaluation of cell death pathways and genes related to dendritic spine plasticity revealed that 
some of them are altered at lower concentrations than which produces the effects observed and below the No Observed Adverse 
Effect (NOAEL). 
Conclusions: The present finding suggest that the use of gene expression profile could be a more sensitive and accurate way to 
determine the NOAEL.
Keywords: Basal forebrain cholinergic neurons, chlorpyrifos, necrosis, apoptosis, dendritic spines, LOATEL, health legislation
Resumen
Introducción: El clorpirifos (CPF) es un insecticida organofosforado que tras la exposición aguda y repetida, induce disfunciones de 
los procesos de aprendizaje y memoria, aunque el mecanismo por el cual se produce este efecto no se conoce por completo. El 
CPF produce en la región cerebral basal anterior la pérdida de neuronas colinérgicas, que participan en la regulación de los procesos 
de aprendizaje y la memoria, pudiendo ser esta la causa de tales trastornos cognitivos. Se ha observado que este efecto está medi-
ado a través del proceso de apoptosis, aunque también se ha descrito que se produce necrosis neuronal tras la exposición a CPF. 
Por otra parte, también se ha demostrado que las espinas dendríticas participan en la regulación de los procesos de aprendizaje y 
memoria y su disrupción también podría contribuir a la alteración de dichos procesos. En este sentido, se ha descrito que el CPF 
altera la densidad de las espinas dendríticas en la corteza prefrontal y el hipocampo tras la exposición aguda y repetida a dosis sub-
clínicas, respectivamente, por lo que su perturbación en las neuronas colinérgicas de la región basal anterior también podría mediar 
estos trastornos cognitivos. 
Objetivos y métodos: De acuerdo con lo expuesto, nosotros hipotetizamos que el CPF induce, en las neuronas colinérgicas de 
la región basal anterior, una alteración de las espinas dendríticas a bajas concentraciones y a concentraciones más altas produce 
muerte celular por apoptosis y necrosis. Evaluamos en neuronas colinérgicas SN56 de la región basal anterior, el efecto del CPF 
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después de 24 horas y 14 días de exposición sobre las espinas dendríticas, la inducción de necrosis y las vías de expresión génica 
que median la inducción de apoptosis y necrosis. 
Resultados: Este estudio demuestra que el CPF induce, tras la exposición aguda y a largo plazo, una alteración de las espinas den-
dríticas, a concentraciones más bajas de aquellas a las que induce la muerte celular. La evaluación de las vías de muerte celular y los 
genes relacionados con la plasticidad de la espina dendrítica reveló que algunos de estos genes están alterados a concentraciones 
más bajas de aquellas a las que producen muerte celular o alteración de las espinas dendríticas y por debajo del Nivel sin efecto 
adverso observable (NOAEL) . 
Conclusiones: El presente studio sugiere que el uso del perfil de expresión génica podría ser una manera más sensible y precisa 
para la determinación del NOAEL.
Palabras clave: Neuronas colinérgicas de la region basal anterior basal, clorpirifos, necrosis, apoptosis, espinas dendríticas, 
LOATEL, regulación sanitaria
 Chlorpyrifos induces cell death in basal forebrain cholinergic neurons
Introduction 
Chlorpyrifos (CPF) is an organophosphate (OP) insec-
ticide widely used in domestic, agricultural, and indus-
trial applications1. Human epidemiological studies have 
related OPs occupational exposure with neurological 
and neuro-behavioral deficits including impairments of 
learning and memory process2,3. In this regard, CPF has 
been shown to produce learning deficits in rats, after acu-
te and repeated administration4-6. It has been suggested 
that inhibition of cholinesterase activity by CPF could be 
involved in these effects7. However, human studies of 
occupational exposure to OPs often fail to find a signi-
ficant correlation between blood cholinesterase activity 
and neuro-behavioral deficits2,3.
Otherwise, degeneration of septal cholinergic neurons 
that project to hippocampus has been linked to memory 
deficits that result from cholinergic modulation of hippo-
campal synaptic circuit loss8. Degeneration of septo-hip-
pocampal cholinergic neurons, as seen in AD and other 
neurodegenerative diseases, results in loss of cholinergic 
modulation of septo-hippocampal synaptic circuits that 
leads to memory deficits8. In fact, the severity of memory 
deficit is strongly correlated with the degree of choliner-
gic cell loss9. Thus, cholinergic neuronal loss in this re-
gion could be related with CPF impairment of memory 
function among other actions10.
In this regard, Lopez-Granero et al4 reported that chronic 
dietary exposure in rats produced cognitive and emo-
tional disorders related with changes in AChE forms. In 
addition, Del Pino et al11 reported that CPF induced, af-
ter acute and long-term exposure, apoptotic cell death 
in cholinergic neurons from the basal forebrain and this 
effect was independent of AChE inhibition and acetylcho-
line level alteration, but was mediated partially by AChE-R 
and AChE-S overexpression, supporting the idea that the 
cognitive disorders reported after CPF exposures may be 
produced by induction of basal forebrain cholinergic cell 
loss mediated partially through AChE forms alteration. In 
addition, CPF has also been reported to induce neuronal 
cell death through necrosis process after CPF acute and 
long-term exposure12,13, thus the cell death observed 
could be also mediated through necrosis induction by 
CPF. In this regard, previously Del Pino et al14 reported 
that AChE-R and AChE-S overexpression induces at low 
concentrations apoptosis and necrosis at high concen-
trations in basal forebrain cholinergic neurons, supporting 
our hypothesis. 
Otherwise, loss of dendritic spines has been reported in 
neurodegenerative disorders as AD affecting mostly selec-
tive neuronal networks of critical importance for memory 
and cognition, such as the basal forebrain cholinergic 
system, the medial temporal regions, the hippocampus 
and many neocortical association areas15 inducing cogni-
tive disorders16,17. In this regard, CPF has been reported 
to induce an alteration in the dendritic spines density in 
the prefrontal cortex and hippocampus after acute and 
repeated exposure to subclinical doses respectively18,19. 
Moreover, cognitive disorder has been reported to be 
produce from subclinical doses and from a lower doses 
from which basal forebrain cholinergic cell loss has been 
reported20, as happens with dendritic spines alteration. 
According to these data, we hypothesized that CPF in-
duces basal forebrain cholinergic dendritic spine altera-
tion at low concentrations and at higher concentrations 
produces neuronal loss through necrosis and apoptosis. 
The present work intends to study the CPF mechanisms 
of basal forebrain cholinergic neuronal loss and dendritic 
spine alteration, due to the importance of these effects to 
explain CPF toxicity on cognitive disorders and neurode-
generative diseases symptoms like. To reach this aim we 
treated with CPF for 24 h or repeatedly for 14 days, wild 
type or transfected with siRNA for AChE, SN56 cells from 
basal forebrain as an in vitro model of cholinergic neuronal 
cells from this region to research the CPF effect on den-
dritic spines and expression of genes involved in dendritic 
outgrowth, the necrotic cell death induction through AChE 
splice variants alteration and the apoptotic and necrotic 
gene expression pathways related to cell death process. 
Materials and methods 
Chemicals  
The compounds chlorpyrifos (99.99%), poly-L-lysine, 
dibutyryl-cAMP, retinoic acid, 3,3´-diaminobenzidinetetra-
chloride, anti-microtubule-associated protein-2 (MAP-2) 
monoclonal antibody and paraformaldehyde were obtai-
26 Medicina Balear 2016; 31 (1); 24-34 
Paula Moyano et al. Chlorpyrifos induces cell death in basal forebrain cholinergic neurons
ned from Sigma (Madrid, Spain). All other chemicals were 
reagent grade of the highest laboratory purity available.
Culture of SN56 cells  
SN56 cells, a cholinergic murine neuroblastoma cell line 
derived from septal neurons21, were used as a model 
of cholinergic neurons from basal forebrain to evaluate 
CPF toxic effects on this specific type of neurons and the 
mechanisms through which they are induced. The cells 
were maintained at 37ºC and 5% CO2 in Dulbecco’s Mo-
dified Eagle’s Medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS), penicillin/streptomycin, 2 mM 
L-glutamine (Sigma, Madrid, Spain), and 1 mM sodium 
pyruvate. Medium was changed every 48 h22. Differen-
tiation of the cells was achieved by culturing for 3 days 
with 1 mM dibutyryl-cAMP and 1 µM retinoic acid as des-
cribed23,24, which produce morphological maturation and 
3-4-fold increase of ChAT activity and acetylcholine level 
in the cells. Differentiated cells have been reported to be 
more sensitive to neurotoxic compound that affects cho-
linergic pathways23,24.
In order to determine the dendritic spine density, the ce-
llular lactate dehydrogenate (LDH) content in wild type 
and siRNA AChE transfected cells, the apoptotic and 
necrotic main gene expression pathways, and the ex-
pression of the main genes related with dendritic spines 
plasticity, cells were seeded in 6-well plates at a density 
of 106 cells/well. Cells were treated for 24 h or for 14 
days with CPF in concentrations between 0.01 µM to 
70 µM and 0.01 µM to 40 µM respectively. At least 3 
replicate wells/treatment were used. A vehicle group was 
employed in parallel for each experiment as a control.
In the literature, 10–100 µM chlorpyrifos has been routi-
nely used to study chlorpyrifos toxicity25-28, although the-
re are not enough data regarding the relative distribution 
or concentration of CPF in human brain after acute and 
chronic exposure. In addition, studies have shown that 
the blood plasma concentration of CPF from human vo-
lunteers were similar to 0.1 µM29. Moreover, whole-body 
molar concentrations associated with the doses of CPF 
(2.5–25.0 mg/kg/day) used in behavioral experiments 
have been reported to be calculated as ranging between 
approximately 7.0 and 8.0 to 70.0 and 80.0 µM20. The 
NOAEL set for CPF is 0.1 mg/kg bw per day30, which 
would be around 0.3 µM concentration in the tissues 
according to Terry et al20. The used doses appear to 
be relevant to study the cognitive disorders according 
to all described above. Furthermore, we chose CPF 30 
µM concentration, which was the lowest concentration 
observed to induce cell death after acute exposure11, to 
study the CPF necrotic and apoptotic mechanisms.
Lactate dehydrogenase (LDH) assay
The necrotic cell death was assessed by measuring the 
LDH released into the culture medium using Lactate De-
hydrogenase Activity Assay Kit (Sigma-Aldrich, Madrid, 
Spain) according to the manufacturer’s instructions. Brie-
fly, the culture medium was removed and pipetted into 
96-well plates. The Master Mix reagent was added, and 
after 3 min colorimetric intensity was determined at 450 
nm over every 5 min using a microplate spectrophoto-
meter (Fluoroskan Ascent FL Microplate Fluorometer and 
Luminometer, ThermoFisher Scientific, Madrid, Spain).
Gene knockdown 
SN56 cells were transfected with siRNAs in 6-well plates 
(1 x106 cells/well) using HiPerfect Transfection reagent 
according to the manufacturer’s instructions (Qiagen, 
Barcelona, Spain). Two sets of siRNA duplexes (Qiagen, 
Barcelona, Spain) homologous to mouse AChE sequen-
ce were designed using the Hi-Performance Design Al-
gorithm (Norvatis AG) and were purchased from Qiagen 
(catalog numbers GS11423 a). As a transfection control, 
an All Stars Negative Control siRNA (Qiagen, Barcelona, 
Spain) was used. 48 h after transfection, the efficiency 
of siRNA-mediated AChE was determined by RT-PCR 
using primers specific for mouse AChE mRNA (Qiagen, 
Barcelona, Spain). The effects of AChE knockdown on 
cell injury were tested by LDH cell viability assay. After 24 
h of incubation with the siRNAs, the cells were washed 
with PBS and incubated for a further 24 h or 14 days in 
culture medium with or without CPF.
Protein determination 
At the end of the treatments, SN56 cells were washed 
with pre-chilled PBS, collected by scrapping, and lysed 
using RIPA buffer (Thermo Scientific, Madrid, Spain) with 
freshly added protease inhibitors cocktail (ThermoFisher 
Scientific, Madrid, Spain). After centrifugation at 10,000 
x g for 10 min at 4ºC, cell lysate supernatant was collec-
ted. Protein concentration was assayed using a BCA kit 
(ThermoFisher Scientific, Madrid, Spain) and normalized.
Dendritic spines density determination.
SN56 differentiated cell were suspended in DEMEM me-
dium. Cells suspension was plated at a density of 106 
cell/ml onto poly-L-lysine 0.10 mg/mL coated glass co-
verslips (22 mm diameter) placed in plastic Petri dishes 
(35 mm diameter) coated with poly-L-lysine. Coverslips 
with adhered SN56 cells were fixed with ice-cold 4% (w/v) 
paraformaldehyde for 15 min and then placed into 0.5 M 
potassium/PBS (KPBS) until use. Coverslips were was-
hed three times in KPBS, and cells were permeabilized 
with 50% ethanol for 1 h and blocked with 10% normal 
goat serum in 0.1% Triton X-100-supplemented KPBS 
(0.1% KPBST). After three 15 min KPBS washes, covers-
lipped cells were then incubated overnight in primary anti-
microtubule-associated protein-2 (MAP-2) monoclonal 
antibody at 1:1000 dilution in 0.1% KPBST at 4°C. Three 
washes of 0.1% KPBST was then followed by immersion 
for 2 h in secondary anti-mouse antibody conjugated to 
biotin (Vector Laboratories) diluted 1:500 in 0.1% KPBST, 
washed in 0.1% KPBST, and visualized using Vectastai-
navidin–biotin horseradish peroxidase complex (Vector 
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Laboratories, Barcelona, Spain) at 1:1000 dilution in 0.1% 
KPBST for 1 h before staining with 0.05% (w/v) 3,3´-dia-
minobenzidinetetrachloride, 0.005% (v/v) H2O2, and 2.5% 
(w/v) nickel (II)sulfate in 0.175 M sodium acetate31. MAP-2 
protein is not localized in dendritic spines but allows for 
accurate quantification of dendritic spine density. 
Real-time PCR analysis
Total RNA was extracted using the Trizol Reagent method 
(Invitrogen, Madrid, Spain). The final RNA concentration 
was determined using a spectrophotometer Nanodrop 
2000 (ThermoFisher Scientific, Madrid, Spain) and the 
quality of total RNA samples was assessed using an Ex-
perionLabChip (Bio-Rad, Madrid, Spain) gel. First-strand 
cDNA was synthesized with 1000 ng of cRNA by using 
a PCR array first strand-synthesis kit (C-02; SuperArray-
Bioscience, Madrid, Spain) following the manufacturer’s 
instructions and including a genomic DNA elimination 
step and external RNA controls. After reverse transcrip-
tion, we performed QPCR using the mouse Cell Death 
PathwayFinder PCR Array (PAMM-212Z) used to analyze 
mRNA levels of 84 key genes involved in cell death, in a 
96-well format, according to the manufacturer’s instruc-
tions (SABiosciencesInc). Reactions were run on a CFX96 
using Real-Time SYBR Green PCR master mix PA-012 
(SABiosciencesInc). The thermocycler parameters were 
95°C for 10 minutes, followed by 40 cycles of 95°C for 
15 seconds and 60°C for 1 minute. Relative changes in 
gene expression were calculated via SuperArray PCR 
Array Data Analysis Software using the cycle threshold 
(Ct) method with normalization of the raw data to several 
housekeeping genes. The expression data are presented 
as actual change multiples. We also performed QPCR 
using prevalidated primer sets (SuperArray Bioscience) 
for mRNAs encoding Postsynaptic Density Protein 95 
(PSD95; PPH01848A), Spinophilin (SPN; PPM34114A), 
Synaptophysin (SYP; PPM03241A), N-Methyl-D-As-
partate Receptor Subunit NR1 (NMDAR1;PPH01823F), 
AChE (PPM35356A), and ACTB (PPM02945B). We used 
ACTB as an internal control for normalization. Reactions 
were run on a CFX96 using Real-Time SYBR Green PCR 
master mix PA-012 (SuperArray Bioscience). The thermo-
cycler parameters were 95°C for 10 minutes, followed by 
40 cycles of 95°C for 15 seconds and 72°C for 30 se-
conds. Relative changes in gene expression were calcu-
lated using the Ct (cycle threshold) method. The expres-
sion data are presented as actual change multiples32 
(Livak and Schmittgen 2001).
We chose PSD95, NMDAR1, SPN and SYP genes to 
determine the effect of CPF on dendritic spine density, 
because both genes are the main regulators of dendritic 
spine plasticity33,35. 
Statistical analysis
At least three replicates for each experimental condition 
were performed, and the presented results were repre-
sentative of these replicates. Data are represented as 
means ± standard deviation (SD). Comparisons bet-
ween experimental and control groups were performed 
by Student’s t test and ANOVA analyses followed by the 
Tukey post-hoc test. Statistical difference was accepted 
when p≤ 0.05. Statistical analysis of data was carried out 
by computer using GraphPad software.
Results 
Effect of CPF on SN56 cell viability  
We used the LDH assay to evaluate cell survival after 24 
h and 14 days exposure to CPF at increasing concen-
trations. LDH is released from cells as a result of loss of 
plasma membrane integrity and it is indicative of necrotic 
cell death mechanism. An increased LDH release to the 
medium was observed in a dose dependent way after 
24 h and long-term CPF exposure from 50 µM and 20 
µM concentrations respectively compared with vehicle-
treated cells (control negative) (Figure 1). Moreover, after 
CPF treatment of SN56 AChE silenced cells amelioration 
in LDH release was also observed (Figure 1). There was 
no significant difference between data of vehicle-treated 
cells and control cells.
AChE gene knockdown
To investigate the protection afforded by the knockdown 
of the AChE during cell death, we introduced siRNA oli-
gonucleotides into SN56 cells by transfection directed 
against AChE. Transfection of cells with control siRNA 
showed no effect on AChE gene expression or cell viabi-
lity, but the AChE siRNA caused large reductions in AChE 
gene expression (Figure 2). Cultures transfected with 
control siRNA compared with culture transfected against 
AChE, showed no effect in cell viability by LDH assays 
(Figure 2).
Effect of CPF on dendritic spine density
We observed that CPF induces acute (from 1 µM) and 
long-term (from 0.1 µM), concentration-dependent, re-
duction in the number of dendritic spine-like processes 
per length of neurite compared with vehicle treated on 
SN56 cultured neurons (Figure 3). There was no effect 
of treatment on mean soma size or the number of neuri-
tes per neuron (Data not shown).
Real-time PCR analysis 
After incubation for 24 h and 14 days with 0.01 µM and 
30 µM concentrations of CPF in SN56 cells, necrotic and 
apoptotic gene expression profile of CPF was analyzed 
with our Real-time PCR arrays. Moreover, the CPF effect 
on AChE and the main regulator dendritic spines synaptic 
plasticity gene expression in AChE silenced Cells and wild 
type respectively were analyzed. The gene expression 
profile of CPF was significantly different from normal con-
trol. The results show that after 24 h and 14 days exposu-
re at 0.01 µM concentration of CPF only the expression of 
TNF, TNFRSF1A, TNFRSF10A, TNFRSF11B proapoptotic 
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genes, TRAF2, BICR2 and BIRC3 antiapoptotic genes 
and MAG, S100A7A and KCN1P1 genes related with ne-
crosis process was induced (Table I and II). Moreover, 
after 24 h exposure at 30 µM concentration of CPF 27 ge-
nes were up-regulated and 5 genes were down-regulated 
with a fold change higher and lower than 1.5 respectively 
for CPF compared with normal control (Table I). In addi-
tion, after and 14 days exposure at 30 µM concentration 
of CPF 43 genes were up-regulated and 7 genes were 
down-regulated with a fold change higher and lower than 
1.5 respectively for CPF compared with normal control 
(Table II). Finally, we observed that after acute (from 0.01 
µM) and long term (from 0.01 µM) CPF exposure, a con-
centration-dependent reduction in PSD95 and SYP gene 
expression (Figure 4A and 4B), but we only observed 
a concentration-dependent gene expression reduction of 
SPN and NMDANR1 after acute exposure from 1 µM CPF 
concentration and after long-term exposure from 0.1 µM 
CPF concentrations (Figure 4C and 4D). 
Discussion 
In the present work we show that CPF induces acute 
(from 50µM) and long-term (from 20 µM), concentration-
dependent, necrotic cell death on septal SN56 choliner-
gic basal forebrain neurons. These results are suppor-
ted by previous works which showed that CPF induced 
neuronal cell death through necrosis process after CPF 
acute and long-term exposure12,13. Previously, we found 
that CPF induces acute (from 30µM) and long-term (from 
1 µM), concentration-dependent, cell death on septal 
SN56 cholinergic basal forebrain neurons, showing that 
apoptotic process is involved in this effect mediated par-
tially by AChE variants overexpression11. Moreover, we 
show that the increase in LDH release was mediated par-
tially by AChE overexpression. In this regard, Del Pino et 
Figure 1: CPF (0.01 to 70 µM) effect on cell viability of SN56 wild type or AChE silenced was determined by LDH release assays. Results are expressed as percentages 
of LDH release after subtracting the control values. Data represents the mean ± SD of three separate experiments from cells of different cultures, each one performed in 
triplicate. ***p<0.001 compared to control. &&&p≤0.001 compared to CPF treatment. 
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al14 reported that AChE-R and AChE-S overexpression 
induces at low concentrations apoptosis and necrosis at 
higher concentrations in basal forebrain cholinergic neu-
rons, supporting our results. Basal forebrain cholinergic 
neurons loss has been related with cognitive deficits36-40. 
In fact, the severity of memory deficit is strongly corre-
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Figure 3: Effects of different CPF concentrations for 24 h or 14 days on dendritic spine density were determined in neurite SN56 cells. Dendritic spine density is indicated 
as % of control (CTL, white column). Data represents the mean ± SD of three independent experiments in triplicate. ***p<0.001 compared to control. 
Figure 4: Shows results from real-time PCR arrays targeting (A) PSD95, (B) SYP, (B) SPN and (D) NMDAR1 genes after 24 h and 14 days CPF treatment. SD95, SYP, 
SPN and NMDAR1 gene expression was compared with controls. Each bar represents mean ± SD of 6 samples. Levels were measured using QPCR. ACTB was used 
as an internal control. ***p<0.001, significantly different from controls. 
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lated with the degree of cholinergic cell loss9. Thus, the 
observed effects on cholinergic basal forebrain neurons 
may be, in part, responsible for the learning deficits and 
neurodegenerative disease symptoms like observed af-
ter acute and long-term exposure to CPF.
Moreover, after acute (from 0.01 µM) and long-term (from 
0.01 µM) CPF exposure we only observed an induction 
in the gene expression of TNF, TNFRSF1A, TNFRSF10A, 
TNFRSF11B proapoptotic genes, TRAF2, BICR2 and 
BIRC3 antiapoptotic genes and MAG, S100A7A and 
KCN1P1 genes related with necrosis process. Apoptosis 
is triggered through the extrinsic pathway when extrace-
llular stimuli and the cytokines CD40L, FASLG, TNFSF10 
and TNF-α inducing cytokine receptors, including FAS 
receptor and tumor necrosis factor super family recep-
tors (TNFRs) like TNFRSF1A, TNFRSF1B, TNFRSF10B 
and CD40, are activated41,42. Inhibitors of apoptosis 
BIRC3 and BIRC2, through TRAF2, can prevent its acti-
vation43. According to this, CPF could activate cell death 
through extrinsic partway, but was blocked by activation 
of apoptosis inhibitors. Otherwise, MAG and S100A7A 
genes have been related with necrosis induction44 and 
KChIP1 expression has been reported to play a protecti-
ve role against cell death and its downregulation leads to 
the induction of necrotic cell death45. Therefore, KChIP1 
overexpression after CPF exposure could be a protective 
mechanism against cell injury produced by CPF. 
In addition, after acute (30 µM) CPF exposure the gene 
expression resultant showed a fold change greater or 
lower than 1.5 in the expression of the 29 genes rela-
ted to apoptosis and necrosis for CPF treatment. Our 
research showed that CPF increased the expression of 
CD40, CD40LG, FAS, FASLG, TNF, TNFRSF10A, TN-
FRSF1A, TNFRSF11B, which likely leaded to induce 
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Table I: Fold-change of cell death related genes after 24 h CPF treatment. Values on red or blue mean a fold change upper or downer than 2
ABL1
AKT1
APAF1
APP
ATG12
ATG16L1
ATG3
ATG5
ATG7
ATP6V1G2
BAX
BCL2
BCL2A1
BCL2L1
BCL2L11
BECN1
BIRC2
BIRC3
BMF
C1orf159
CASP1
CASP2
CASP3
CASP6
CASP7
CASP9
CCDC103
CD40
CD40LG
CFLAR
COMMD4
CTSB
CTSS
CYLD
DEFB1
DENND4A
DFFA
DPYSL4
EIF5B
ESR1
FAS
FASLG
Gene Symbol Gene Symbol
GenBank 
Accession No.
GenBank 
Accession No.
Fold Change Fold Change
0.01µM 0.01µM30µM 30µM
NM_005157
NM_005163
NM_001160
NM_000484
NM_004707
NM_017974
NM_022488
NM_004849
NM_006395
NM_130463
NM_004324
NM_000633
NM_004049
NM_138578
NM_006538
NM_003766
NM_001166
NM_001165
NM_033503
NM_017891
NM_033292
NM_032982
NM_004346
NM_032992
NM_001227
NM_001229
NM_213607
NM_001250
NM_000074
NM_003879
NM_017828
NM_001908
NM_004079
NM_015247
NM_005218
NM_005848
NM_004401
NM_006426
NM_015904
NM_000125
NM_000043
NM_000639
NM_012188
NM_000152
NM_001924
NM_014568
NM_002086
NM_024610
NM_002111
NM_000619
NM_000618
NM_000875
NM_000207
NM_001145805
NM_020655
NM_014592
NM_002361
NM_181509
NM_002750
NM_021960
NM_003998
NM_003946
NM_001004467
NM_001618
NM_005484
NM_002647
NM_006505
NM_020387
NM_003161
NM_176823
NM_000345
NM_006038
NM_003900
NM_014258
NM_018202
NM_000594
NM_003844
NM_002546
NM_001065
NM_000546
NM_021138
NM_017853
NM_003565
NM_001167
FOXI1
GAA
GADD45A
GALNT5
GRB2
HSPBAP1
HTT
IFNG
IGF1
IGF1R
INS
IRGM
JPH3
KCNIP1
MAG
MAP1LC3A
MAPK8
MCL1
NFKB1
NOL3
OR10J3
PARP1
PARP2
PIK3C3
PVR
RAB25
RPS6KB1
S100A7A
SNCA
SPATA2
SQSTM1
SYCP2
TMEM57
TNF
TNFRSF10A
TNFRSF11B
TNFRSF1A
TP53
TRAF2
TXNL4B
ULK1
XIAP
1,11b
1,02
1,15b
1,16a
1,17a
1,21a
1,04
1,01
1,04
1,02
1,05
1,10b
1,02
1,13a
1,01
1,03
1,72a
1,69a
1,06
1,13a
1,05
1,01
1,05
1,06
1,02
1,01
1,07
1,08
1,06
1,21a
1,02
1,13a
1,08
1,12a
1,01
1,03
1,05
1,01
1,03
1,04
1,02
1,06
1,12a
1,09
1,11a
1,03
1,06
1,05
1,06
1,07
1,01
1,02
1,07
1,13b
1,09
2,51a
2,12a
1,08
1,07
1,14a
1,02
1,05
1,01
1,11a
1,06
1.07
1,06
1,03
1,27a
2,17a
1,06
1,12a
1,17a
1,03
1,11a
1,53a
1,61a
2,01b
1,75a
1,10
2,22a
1,01
1,02
1,05
0,07
1,19a
2,24a
1.05
1,09
1,13a
1,23a
1,08
1,14a
1,09
1,11b
1,28a
1,06
3,21a
2,69a
2,35a
1,17b
1,27a
1,06
1,04
1,07
1,03
1,01
1.05
1,10a
1,02
1,31a
2,47a
1,25a
2,41a
1,12a
1,66a
1,15a
1,69a
1,78a
2,37b
1,91a
1,67a
2,72a
1,69a
1,04
1,01
1,23a
1,05
2,52a
1,41a
1,13a
1,16a
1,11a
1,21a
1,04
1,02
2,54a
1,15a
1,04
2,23a
2,32a
1,06
-1,43a
-1,59a
1,06
1,16a
2,21a
1,09
1,57a
1,25a
2,31a
1,69a
1,05
3,31a
3,56a
1,11a
1,02
1,05
1,04
1,08
1,01
1,33a
1,09
1,05
1,33b
1,07
2,31a
2,13a
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a p < 0.001 compared to the control.    b p < 0.05 compared to the control.
Table II: Fold-change of cell death related genes after 14 days CPF treatment. Values on red or blue mean a fold change upper or downer than 2
ABL1
AKT1
APAF1
APP
ATG12
ATG16L1
ATG3
ATG5
ATG7
ATP6V1G2
BAX
BCL2
BCL2A1
BCL2L1
BCL2L11
BECN1
BIRC2
BIRC3
BMF
C1orf159
CASP1
CASP2
CASP3
CASP6
CASP7
CASP9
CCDC103
CD40
CD40LG
CFLAR
COMMD4
CTSB
CTSS
CYLD
DEFB1
DENND4A
DFFA
DPYSL4
EIF5B
ESR1
FAS
FASLG
Gene Symbol Gene Symbol
GenBank 
Accession No.
GenBank 
Accession No.
Fold Change Fold Change
0.01µM 0.01µM30µM 30µM
NM_005157
NM_005163
NM_001160
NM_000484
NM_004707
NM_017974
NM_022488
NM_004849
NM_006395
NM_130463
NM_004324
NM_000633
NM_004049
NM_138578
NM_006538
NM_003766
NM_001166
NM_001165
NM_033503
NM_017891
NM_033292
NM_032982
NM_004346
NM_032992
NM_001227
NM_001229
NM_213607
NM_001250
NM_000074
NM_003879
NM_017828
NM_001908
NM_004079
NM_015247
NM_005218
NM_005848
NM_004401
NM_006426
NM_015904
NM_000125
NM_000043
NM_000639
NM_012188
NM_000152
NM_001924
NM_014568
NM_002086
NM_024610
NM_002111
NM_000619
NM_000618
NM_000875
NM_000207
NM_001145805
NM_020655
NM_014592
NM_002361
NM_181509
NM_002750
NM_021960
NM_003998
NM_003946
NM_001004467
NM_001618
NM_005484
NM_002647
NM_006505
NM_020387
NM_003161
NM_176823
NM_000345
NM_006038
NM_003900
NM_014258
NM_018202
NM_000594
NM_003844
NM_002546
NM_001065
NM_000546
NM_021138
NM_017853
NM_003565
NM_001167
FOXI1
GAA
GADD45A
GALNT5
GRB2
HSPBAP1
HTT
IFNG
IGF1
IGF1R
INS
IRGM
JPH3
KCNIP1
MAG
MAP1LC3A
MAPK8
MCL1
NFKB1
NOL3
OR10J3
PARP1
PARP2
PIK3C3
PVR
RAB25
RPS6KB1
S100A7A
SNCA
SPATA2
SQSTM1
SYCP2
TMEM57
TNF
TNFRSF10A
TNFRSF11B
TNFRSF1A
TP53
TRAF2
TXNL4B
ULK1
XIAP
1,15b
1,07
1,18a
1,19a
1,18a
1,19a
1,07
1,04
1,03
1,01
1,09
1,13a
1,05
1,08
1,07
1,07
1,86a
1,82a
1,09
1,12a
1,02
1,03
1,07
1,04
1,03
1,06
1,13a
1,08
1,06
1,21a
1,02
1,13a
1,05
1,10b
1,04
1,01
1,03
1,06
1,01
1,02
1,05
1,03
1,15a
1,04
1,14a
1,06
1,04
1,07
1,03
1,05
1,06
1,03
1,06
1,10b
1,05
2,62a
2,25a
1,04
1,02
1,10b
1,03
1,06
1,05
1,13a
1,02
1.05
1,08
1,04
1,15a
2,28a
1,03
1,10b
1,12a
1,05
1,13a
1,59a
1,72a
2,14b
1,83a
1,18
2,31a
1,11
1,09
1,06
2,14a
1,32a
2,22a
-1,64
2,51a
1,69a
1,13a
1,02
1,16a
1,05
1,11a
1,29a
2,38a
-3,67a
-3,42a
2,42a
1,21b
1,29a
1,07
1,02
-3,67a
1,74a
1,81a
2,28a
1,49a
1,04
1,19a
-2,73a
1,29a
2,36a
1,19a
1,67a
1,24a
1,66a
1,79a
2,26b
1,91a
1,85a
3,14a
1,69a
1,02
1,04
1,32a
1,08
2,56a
1,31a
1,24a
1,33a
1,19a
1,62a
1,84a
1,59a
2,69a
1,19a
1,08
2,27a
2,34a
1,09
-1,62a
-1,53a
2,95a
3,76a
2,19a
1,15a
1,72a
1,23a
2,22a
1,68a
2,31a
4,48a
3,16a
1,27a
2,12a
2,52a
2,26
2,22a
1,93a
1,35b
1,03
2,81
1,33b
1,01
2,36a
2,46a
apoptosis through extrinsic pathway. CPF increased also 
the expression of TRAF2 and decreased BIRC3 and 
BIRC2 antiapoptotic genes allowing caspases activation 
which expression was increased. Besides, CPF indu-
ced GADD45A, and TP53 genes expression. The P53-
GADD45A pathway has been shown to primarily play a 
role in the control of G2-M arrest following certain DNA-
damaging agents46,47, thus their induction could lead to 
cell arrest. Moreover, CPF increased the expression of 
BAX and BCL2L11 proapoptotic genes and BCL2L1 
antiapoptoptic gene48, further decrease the ratio BCL2/
BAX which regulated the induction of apoptosis49 leading 
to apoptosis. Finally, CPF increased the expression of 
CASP1, CASP3, CASP7, CASP9 which executed apop-
tosis. Besides, CPF increased the expression of KC-
N1P1, MAG and S100A7A genes related to necrosis as 
happened at lower concentrations indicating that necro-
sis is prevented. 
After long-term CPF exposure (30 µM), besides the 
effect on the same genes commented after acute ex-
posure, CPF increased the expression of ATP6VG2, 
BMF, CLORF159, CCDC103, COMMD4, CTSB, STSS, 
CYLD, DEFB1, DPYSL4, FOXIL1, GRB2, HSPBAP1, 
JPH3, PARP1, PARP2, PIK3C3, PVR, TXNL4B and de-
creased the expression of GALNTL5, OR10J3, KCN1P1, 
MAG and S100A7A genes related to necrosis according 
with the research of Hitomi et al44. Our study indicates 
that CPF exerts its cell death effects by involving apopto-
sis and necrosis pathways.
Otherwise, we observed that CPF induces acute (from 1 
µM) and long-term (from 0.1 µM), concentration-depen-
dent, reduction in the number of dendritic spine density 
on septal SN56 cholinergic basal forebrain neurons. In this 
regard, CPF has been reported to induce an alteration in 
the dendritic spines density in the prefrontal cortex and hip-
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pocampus after acute and repeated exposure to subclini-
cal doses respectively18,19, supporting our results. Dendritic 
spines loss has been reported in neurodegenerative disor-
ders as AD, affecting mostly selective neuronal networks of 
critical importance for memory and cognition, such as the 
basal forebrain cholinergic system, the medial temporal re-
gions, the hippocampus and many neocortical association 
areas15 inducing cognitive disorders16,17. Moreover, cogni-
tive disorders have been reported to be produced from 
subclinical doses and from lower doses from which basal 
forebrain cholinergic cell loss has been reported20, as hap-
pens with dendritic spines alteration, suggesting that both 
processes are implicated in cognitive disorders induction, 
at low doses only through dendritic spine alteration and at 
higher doses through both mechanisms. 
In addition, we observed that after acute (from 0.01 µM) 
and long term (from 0.01 µM) CPF exposure, a concentra-
tion-dependent downregulation in PSD95 and SYP gene 
expression was produced. It has been suggested that SYP 
plays a role in formation and stabilization of synapses50, 
regulating dendritic spine density and shape51,52. Moreover, 
PSD95 was described to play a role in determining the 
size and the strength of synapses53,54, formation of synap-
se assemblies54 and spine-maturation55,56. Therefore, both 
genes alteration could be implicated in the effects obser-
ved on dendritic spines. Our results show that PSD95 and 
SYP gene expression is altered below the concentration 
from which dendritic spine density disruption is evident, 
which indicates that the harmful effects of CPF exposure 
on dendritic spines could be started and detected before 
they would be manifest and these genes could be used 
as biomarker of this effect. Moreover, PSD95 and SYP are 
both involved in dendritic spine morphology regulation and 
their alteration by CPF exposure may be involved with a 
disruption of dendrite spine shape, contributing to the cog-
nitive disorders observed. Otherwise, we only observed a 
concentration-dependent SPN and NMDANR1 gene ex-
pression downregulation after acute exposure from 1 µM 
CPF concentration and after long-term exposure from 0.1 
µM CPF concentrations as seen with dendritic spines den-
sity reduction, suggesting both genes are directly correla-
ted with this effect. In this regard, SPN, a key cytoskeletal 
protein in the formation and maintenance of dendritic spi-
nes, has been reported to modulate dendritic morphology 
and number33 and an increase in dendritic spine densi-
ty has been correlated with an increase in the spinophilin 
expression34. In addition, N-methyl-D-aspartate (NMDA) 
receptor, is also involved in synaptic plasticity as well as 
learning and memory processes regulation57 and the N-
methyl-D-aspartate receptor antagonists reduce dendritic 
spine density and neurite growth35. Future studies are nee-
ded to determine the implication of these genes in dendritic 
spine shape and density disruption mechanisms. 
According to all exposed above, CPF induced changes on 
cell death and dendritic spines plasticity pathways were 
detected at doses below those required to induce manifest 
apoptotic and necrotic cell death and alter dendritic spines 
plasticity. These results support the suggestion that gene 
expression changes could potentially be more sensitive 
measures of effects at early stages and at lower doses 
than many typical toxicological measures58 and that alte-
red toxicogenomic profiles contributing to toxicologically-
relevant pathways provide useful tools for more precise 
determination of toxicological mechanisms as compared 
to traditional toxicological endpoints and for reducing un-
certainty in establishing lowest observed adverse effect le-
vel (LOAEL), no observed adverse effect level (NOAEL), or 
benchmark dose (BMD)59-62. Therefore, the toxicogenomic 
profile analysis could offer means to improve human health 
risk assessment generally based on standard toxicity test 
results. Previously, this approach has been employed in 
different studies as the published by Lobenhofer et al60 
that examines in vitro transcriptional responses to very low 
concentrations of estrogen, confirming that estrogen con-
centrations below those which are physiologically relevant 
did not induce a measurable transcriptional response. That 
concentration threshold was referred to as the No Obser-
vable Transcriptional Effect Level (NOTEL). In our study, it 
was shown that the CPF Lowest Observed Adverse Trans-
criptional Expression Levels (LOATEL) for 12 responding 
genes was at least 100-fold lower than the NOAEL that 
was based on observable inhibition of erythrocyte acetyl-
cholinesterase activity in humans30. Therefore, lower doses 
would be needed in order to observe no transcriptional 
effects. Examination of data from the group of 12 respon-
ding genes leads us to propose 0.003-0.004 mg/kg/day 
as LOATEL for CPF. The present study did not, therefore, 
establish a No Observed Adverse Transcriptional Effect 
Level (NOATEL) for CPF. These subclinical transcriptio-
nal changes may be employed as predictors of adverse 
effects from toxic compounds exposure and thereby used 
to improve risk assessment and safety evaluation. Further 
studies are required to confirm this LOATEL.
Conclusion  
Taking all together, it can be concluded that after acute and 
long-term exposure, CPF induces at low concentration a 
dendritic spine density reduction and at higher concentra-
tions induces cell death on cholinergic neurons from basal 
forebrain through apoptotic and necrotic mechanisms, de-
pending on the exposure concentration mediated in part 
though AChE variants overexpression and these effects 
were initiated at lower concentration that which they are 
manifest, as indicated by transcriptional alterations of key 
genes. Our results, particularly those for CPF treatment, 
suggest that toxicogenomic profiles provide a sensitive 
tool for identifying and characterizing thresholds of toxicity 
for potentially toxic compounds based upon a transcrip-
tome-level of insight into their mechanisms. These effects 
could explain cognitive alterations and neurodegenerative 
diseases induced by CPF. In this regard, all the mecha-
nisms that we reported to induce cholinergic cell loss in 
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basal forebrain have been described to be involved with 
the induction of cognitive disorders, which supports this 
hypothesis. Future studies should be developed to de-
termine the other mechanisms implicated in these effects 
observed on cholinergic neurons. These results are of in-
terest, since they provide new information on the mecha-
nisms that mediate dendritic spine density alteration and 
cell death induce by CPF, and because they lead to a bet-
ter understanding of some effects related to CPF toxicity 
and highlight the need for a new NOAEL and LOAEL and 
a new risk assessment of this pesticide.
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